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Volume 51, Number 11S Abstracts 31SResults: 88% of all 163 possible access sites were closed
by FS as first choice, traditional cut-down was primarily
performed in 11.4% and percutaneus closure device was
used in 0.6%. 9% of the FS closed access sites were con-
verted to open cut-down closure intraoperatively because
of bleeding (7%) or stenosis (2%). Data from the one year
follow-up show no signs of increased stenosis, thrombosis
or formation of plaque. 4 pseudoaneurysms (3%) were
detected and 2 of these warranted surgical repair.
Conclusions: FS is technically feasible, economically
sound and appears to be a safe and effective method of
closure of femoral access sites after EVAR.Most short-term
complications are easily detected and managed intraopera-
tively. Few long-term complications were detected.
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Objectives: The Endurant (Medtronic) is a new stent-
graft designed to reduce complications while widening the
applicability of EVAR. This study presents the 1-year re-
sults of the Endurant in “real-life practise.”
Methods: All clinical pre-, per- and postoperative data
of Endurant patients of our 3 centers is prospectively col-
lected. Patients undergo CTAs preoperatively, and 1
month and yearly post-EVAR. All patients with completed
1-year follow-up were included. Clinical data, AAA charac-
teristics, presence of endoleaks (EL), graft migration (5
mm), and other EVAR related complications were noted.
All values are stated as mean (range).
Results: 66 AAA patients were included {61 male,
AAA size 63 mm (45-89), AAA volume 202 mL (68-548),
neck length 32 mm (9-70), angulation 39° (0-109)}. Pri-
mary technical success was achieved in 98.5% (1 stent
placed in renal artery) with no primary type I/III ELs or
conversions. Thirty-day mortality was 0%. On the first
postoperative CTA, 10 ELs were seen (15%, all type II).
One-year follow-up showed four iliac limb occlusions (6%,
all due to poor outflow), and 1 infected stentgraft (causing
a type I EL). Five endovascular reinterventions were per-
formed (8%; 4 to treat iliac limb occlusions, 1 proximal
extension cuff). 1-year mortality was 13.7% (9 patients).
AAA-related mortality was 1.5% (the 1 with stentgraft
infection). The mean AAA size had decreased significantly
after 1 year {diameter: 53 mm (32-80), volume: 162 mL(60-400)}, 7 ELs were noted {6 II, 1 type I (neck dilata-
tion), no graft migration}.
Conclusions: This is the first report on 1-year FU data
using the Endurant for AAA treatment. The technical
success rate was very high. Stentgraft migration did not
occur and only 1 type Ia EL was seen. The AAA-related
mortality was 1.5%, but the total 1-year mortality was
relatively high. Iliac limb occlusions were seen relatively
frequently, possibly demanding more frequent prophylac-
tic PTA of outflow vessels.
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Objectives: To evaluate the results of a new aortic
endograft for the treatment of abdominal aortic aneurysms
(AAAs) with challenging neck and/or difficult access.
Methods: The definition of a challenging proximal
neck was based on diameter (28 mm), length (15 mm),
angulations (60°), shape (reverse tapered or bulging),
thrombus lining (50%) and tortuosity. The definition of
difficult access was based on the presence of two or more
90° angulations within an iliac artery and concomitant
occlusive disease with external or common iliac artery di-
ameter less than 7mm. Between September 2008 and No-
vember 2009, 46 patients (39 male, mean age 75.82 years)
were treated with the Endurant stent-graft (Medtronic,
Santa Rosa, CA, USA) in our unit. Nine of the 46 patients
(19.56%) had a challenging neck, 13 (28.26%) had hostile
iliac artery anatomy, and 24 (52.18%) had both. The results
were analyzed in terms of technical success, 1-month mor-
tality and morbidity and aorto-iliac complications (en-
doleaks and iliac injuries).
Results: Technical success was achieved in all cases.
Two (4.34%) type-1 endoleaks were detected on comple-
tion angiography (CA) and solved by means of proximal
ballooning. Three (6.52%) type-2 endoleaks detected on
CA were seen to have resolved spontaneously on 1-month
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before progression of the delivery system and were treated
after CA by PTA and/or stenting. The 1-month mortality
rate was 0% and the major morbidity rate was 2.1% (1/46).
No conversion to open surgery, graft limb thrombosis or
iliac artery injuries were observed.
Conclusions: Our experience shows that the Endurant
stent-graft is safe and effective in the endovascular repair of
AAAs in patients with challenging anatomy.While this graft
enables extreme anatomical difficulties to be overcome,
only skilled operators after a long learning curve should
treat these complex situations. However, further studies are
needed to evaluate the long-term results.
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Objectives: Infected aneurysms remain a therapeutic
challenge. This study evaluated the outcome of surgical
treatment for infected aneurysms.
Methods: This was a retrospective study of patients
treated surgically for infected abdominal aortic or iliac
artery aneurysm at the University of TokyoHospital during
the past 25 years. Patients’demographic data, past history,
symptoms at presentation, aneurysm location, bacteriolog-
ical findings, surgical approach and outcome were evalu-
ated.
Results: During the study period, 740 patients were
treated for abdominal aortic and/or iliac artery aneurysm.
Of them, 19 (2.6 %) were diagnosed with infected aneu-
rysm. There were 16 men. Mean age was 66 years (range
40-83). Eight (42%) had a history of various septic diseases.
Preoperative signs of infection, such as leukocytosis and
elevated C-reactive protein, were found in 68%, and fever
was present in 42%. The aneurysms were localized in the
suprarenal abdominal aorta in 3 patients, infrarenal abdom-
inal aorta in 13, and iliac artery in 3. At the time of surgery,
one (5%) aneurysmwas already ruptured, and 13 (68%) had
penetrated into periaortic tissue, forming a contained rup-
ture. Eleven (58%) had positive blood or aortic wall culture
results; Staphylococcus aureus was the most common or-
ganism. In-situ graft replacement was performed in 16
(84%) patients; of these, 13 (81%) grafts were covered with
an omental flap, and 10 (63%) grafts were soaked with
rifampicin or amikacin. Subsequent in-situ graft infection
occurred in 3 patients. In hospital mortality was 11% andperioperative morbidity was high, 42%. Mean follow-up
was 51 months (range 1-224 months). Cumulative survival
rate at 5 years was 84%. All of the 3 patients who died
during the follow-up period presented with rupture within
5 months postoperatively.
Conclusions: Our experience indicates that an aggres-
sive surgical approach for infected aneurysm is the only way to
improve the outcome of an otherwise disastrous condition.
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Objectives: Serial Computed Tomography (CT) scan-
ning is routinely employed to follow-up endovascular ex-
clusion of abdominal aortic aneurysms. Nonvascular dis-
eases can be identified, and these exams include images of
the lung bases which can provide information that leads to
the diagnosis of pulmonary neoplasms. The purpose of this
report is to determine the rate and type of pulmonary-based
oncologic diseases identified by serial CT scanning of pa-
tients with endovascular repair of AAA.
Methods: A retrospective review of 138 consecutive
patients receiving endovascular AAA exclusion over an
eight year period was performed. Length of follow-up and
number of CT scans performed was recorded. CT charac-
teristics of the lesion (size, character, and suspicion of
malignancy), type of biopsy procedure performed and final
pathologic diagnosis were collected. Oncologic treatments
and survival length were also evaluated.
Results: Eight patients (6%) with pulmonary lesions
were referred for evaluation by thoracic surgeons. Six pa-
tients (4%) underwent biopsy of the lesion, and were diag-
nosed with a primary malignancy. One patient refused
biopsy and is being followed with CT surveillance, and one
patient continues with recommended CT surveillance of
the lesion. The tumor types included four primary lung
cancers (1 small cell and 3 non-small cell), one primary
pulmonary carcinoid tumor, and one B-cell lymphoma.
The patients receiving CT surveillance have had no changes
noted in their lesions. More than half of the cancers were
diagnosed in stage I.
Conclusions: Serial CT scans reveal a high rate of
pulmonary malignancies in a population with AAA. These
results indicate that aggressive management of these lesions
(early thoracic surgery consultation and biopsy) is appro-
priate in this high risk population.
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